Page last updated: 2024-10-28

guanethidine and Prostatic Diseases

guanethidine has been researched along with Prostatic Diseases in 1 studies

Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.

Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carvalho, TL1
Petenusci, SO1
Favaretto, AL1
Kempinas, WG1

Other Studies

1 other study available for guanethidine and Prostatic Diseases

ArticleYear
Morphometric and biochemical evaluation of rat prostate and seminal vesicle following chemical sympathectomy with guanethidine.
    Archives internationales de physiologie et de biochimie, 1990, Volume: 98, Issue:5

    Topics: Animals; Fructose; Guanethidine; Male; Organ Size; Prostatic Diseases; Rats; Rats, Inbred Strains; S

1990